SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-17-042180
Filing Date
2017-08-10
Accepted
2017-08-10 21:28:24
Documents
1
Period of Report
2017-06-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 v473004_form4.html 4  
1 FORM 4 v473004_form4.xml 4 3726
  Complete submission text file 0001144204-17-042180.txt   5301
Mailing Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087
Business Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087 610-254-4201
Aevi Genomic Medicine, Inc. (Issuer) CIK: 0001138776 (see all company filings)

IRS No.: 980217544 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O INSPIREMD, INC. 321 COLUMBUS AVENUE BOSTON MA 02116
Business Address
BARER SOL J (Reporting) CIK: 0001247015 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35112 | Film No.: 171022801